79 related articles for article (PubMed ID: 23490201)
1. C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model.
Chen H; Zhu J
Med Hypotheses; 2013 May; 80(5):679-83. PubMed ID: 23490201
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
4. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis.
Rubino E; Ferrero M; Rainero I; Binello E; Vaula G; Pinessi L
Cephalalgia; 2009 Aug; 29(8):818-25. PubMed ID: 17714520
[TBL] [Abstract][Full Text] [Related]
5. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
Zintzaras E
Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
[TBL] [Abstract][Full Text] [Related]
6. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia.
Xia XP; Chang WW; Cao YX
Hypertens Res; 2012 Dec; 35(12):1129-34. PubMed ID: 22914556
[TBL] [Abstract][Full Text] [Related]
10. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
[TBL] [Abstract][Full Text] [Related]
12. Association between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis.
Song Y; Li B; Wang C; Wang P; Gao X; Liu G
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):679-87. PubMed ID: 26776436
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
Gilbody S; Lewis S; Lightfoot T
Am J Epidemiol; 2007 Jan; 165(1):1-13. PubMed ID: 17074966
[TBL] [Abstract][Full Text] [Related]
14. Association between MTHFR C677T polymorphism and primary open-angle glaucoma: a meta-analysis.
Huo Y; Zou H; Lang M; Ji SX; Yin XL; Zheng Z; Liu W; Chen CL; Yuan RD; Ye J
Gene; 2013 Jan; 512(2):179-84. PubMed ID: 23123730
[TBL] [Abstract][Full Text] [Related]
15. Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers.
Prasad VV; Wilkhoo H
Onkologie; 2011; 34(8-9):422-6. PubMed ID: 21934341
[TBL] [Abstract][Full Text] [Related]
16. MTHFR C677T polymorphisms and childhood acute lymphoblastic leukemia: a meta-analysis.
Wang J; Zhan P; Chen B; Zhou R; Yang Y; Ouyang J
Leuk Res; 2010 Dec; 34(12):1596-600. PubMed ID: 20409583
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder.
Rai V
Cell Mol Biol (Noisy-le-grand); 2011 Sep; 57 Suppl():OL1558-66. PubMed ID: 21955385
[TBL] [Abstract][Full Text] [Related]
18. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil.
de Cássia Carvalho Barbosa R; da Costa DM; Cordeiro DE; Vieira AP; Rabenhorst SH
Anticancer Res; 2012 Nov; 32(11):4805-11. PubMed ID: 23155246
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
20. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
Li XL; Xu JH
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):244-9. PubMed ID: 22370724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
